Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kee-Beom Kim, Yun-Cheol Chae, Arim Han, Joo-Young Kang, Hyeonsoo Jung, Jin Woo Park, Ja Young Hahm, Seryeon Kim & Sang-Beom Seo. (2014) Negative regulation of peroxiredoxin 6 (Prdx 6) transcription by nuclear oncoprotein DEK during leukemia cell differentiation. Animal Cells and Systems 18:5, pages 318-323.
Read now
Read now
Dong-Mei Wang, Ling Liu, Lei Fan, Zhi-Jian Zou, Li-Na Zhang, Shu Yang, Jian-Yong Li & Wei Xu. (2012) Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status. Cancer Biology & Therapy 13:14, pages 1522-1528.
Read now
Read now
Fabián A. Tedeschi, Maria A. Cardozo, Rosanna Valentini & Fabián E. Zalazar. (2010) Co-expression of HoxA9 and bcr-abl genes in chronic myeloid leukemia. Leukemia & Lymphoma 51:5, pages 892-896.
Read now
Read now
Articles from other publishers (42)
Yue Wang, Longfei Dai, Ran Huang, Weisong Li & Wenyong Wu. (2023) Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes. Frontiers in Oncology 13.
Crossref
Crossref
Katherine E. Wilcher, Evan R.H. Page & Lisa M. Privette Vinnedge. (2023) The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia. Experimental Hematology 123, pages 18-27.
Crossref
Crossref
Muhammad Habiburrahman, Muhammad Wardoyo, Stefanus Sutopo & Nur Rahadiani. (2022)
Potential of
DEK
proto‑oncogene as a prognostic biomarker for colorectal cancer: An evidence‑based review
. Molecular and Clinical Oncology 17:1.
Crossref
Crossref
Kazuhisa Ishida, Takayuki Nakashima, Toshiyuki Shibata, Akira Hara & Hiroyuki Tomita. (2020) Role of the DEK oncogene in the development of squamous cell carcinoma. International Journal of Clinical Oncology 25:9, pages 1563-1569.
Crossref
Crossref
Adélia Mendes & Birthe Fahrenkrog. (2019) NUP214 in Leukemia: It’s More than Transport. Cells 8:1, pages 76.
Crossref
Crossref
Marie C. Matrka, Katherine A. Cimperman, Sarah R. Haas, Geraldine Guasch, Lisa A. Ehrman, Ronald R. Waclaw, Kakajan Komurov, Adam Lane, Kathryn A. Wikenheiser-Brokamp & Susanne I. Wells. (2018) Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence. PLOS Genetics 14:3, pages e1007227.
Crossref
Crossref
Nuno Martins, Adélia Mendes & Birthe Fahrenkrog. 2018. Nuclear-Cytoplasmic Transport. Nuclear-Cytoplasmic Transport
223
248
.
Ming-Xu Qiao, Chun Li, Ai-Qun Zhang, Ling-Ling Hou, Juan Yang & Hong-Gang Hu. (2016) Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma. Oncology Reports.
Crossref
Crossref
XIN LIU, DONGDONG QI, JUJIE QI, ZESHU MAO, XIANGDAN LI, JINHUI ZHANG, JINZI LI & WENBIN GAO. (2016) Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma. Oncology Reports 35:1, pages 155-162.
Crossref
Crossref
C Sandén & U Gullberg. (2015) The DEK oncoprotein and its emerging roles in gene regulation. Leukemia 29:8, pages 1632-1636.
Crossref
Crossref
Carl Sandén, Helena Jernmark Nilsson & Urban Gullberg. (2015) The DEK oncoprotein is upregulated by multiple leukemia-associated fusion genes. Blood Cells, Molecules, and Diseases 54:3, pages 284-285.
Crossref
Crossref
Gemma E. Logan, Nirit Mor-Vaknin, Till Braunschweig, Edgar Jost, Pia Verena Schmidt, David M. Markovitz, Ken I. Mills, Ferdinand Kappes & Melanie J. Percy. (2015) DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML). Blood Cells, Molecules, and Diseases 54:1, pages 123-131.
Crossref
Crossref
Junjie Piao, Yongjun Shang, Shuangping Liu, Yingshi Piao, Xuelian Cui, Yuzi Li & Zhenhua Lin. (2014) High expression of DEK predicts poor prognosis of gastric adenocarcinoma. Diagnostic Pathology 9:1.
Crossref
Crossref
Lijuan Lin, Junjie Piao, Wenbin Gao, Yingshi Piao, Guang Jin, Yue Ma, Jinzi Li & Zhenhua Lin. (2013) DEK over expression as an independent biomarker for poor prognosis in colorectal cancer. BMC Cancer 13:1.
Crossref
Crossref
Junying WangLimei SunMingyue YangWenting LuoYing GaoZihui LiuXueshan QiuEnhua Wang. (2013) DEK Depletion Negatively Regulates Rho/ROCK/MLC Pathway in Non–Small Cell Lung Cancer. Journal of Histochemistry & Cytochemistry 61:7, pages 510-521.
Crossref
Crossref
Xin Sun, Bin Liu, Wenyue Ji, Xiaolin Ma, Xinqi Wang & Hui Gu. (2012) The Role of HOXA9 in Human Laryngeal Squamous Cell Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 20:10, pages 467-472.
Crossref
Crossref
Simone Fulda, Krishnaraj Rajalingam & Ivan Dikic. (2012) Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications. EMBO Molecular Medicine 4:7, pages 545-556.
Crossref
Crossref
Haiyan Fu, Guodong Yang, Mengying Wei, Li Liu, Liang Jin, Xiaozhao Lu, Li Wang, Lan Shen, Jing Zhang, Huanyu Lu, Libo Yao & Zifan Lu. (2012) The RNA-binding protein QKI5 is a direct target of C/EBPα and delays macrophage differentiation. Molecular Biology of the Cell 23:9, pages 1628-1635.
Crossref
Crossref
Shuangping Liu, Xiaoyan Wang, Fengdan Sun, Jienan Kong, Zhuhu Li & Zhenhua Lin. (2012) DEK overexpression is correlated with the clinical features of breast cancer. Pathology International 62:3, pages 176-181.
Crossref
Crossref
Andrew G. MunteanJay L. Hess. (2012) The Pathogenesis of Mixed-Lineage Leukemia. Annual Review of Pathology: Mechanisms of Disease 7:1, pages 283-301.
Crossref
Crossref
Yongsheng HuangKajal Sitwala, Joel Bronstein, Daniel Sanders, Monisha Dandekar, Cailin Collins, Gordon Robertson, James MacDonald, Timothee Cezard, Misha Bilenky, Nina Thiessen, Yongjun Zhao, Thomas Zeng, Martin Hirst, Alfred HeroSteven Jones & Jay L. Hess. (2012) Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood 119:2, pages 388-398.
Crossref
Crossref
Sungsin Jo, Hongki Lee, Sojin Kim, Eun Mi Hwang, Jae-Yong Park, Sang Soo Kang & Heekyoung Chung. (2011) Inhibition of PCGF2 enhances granulocytic differentiation of acute promyelocytic leukemia cell line HL-60 via induction of HOXA7. Biochemical and Biophysical Research Communications 416:1-2, pages 86-91.
Crossref
Crossref
Gina M. Kavanaugh, Trisha M. Wise-Draper, Richard J. Morreale, Monique A. Morrison, Boris Gole, Sandy Schwemberger, Elisia D. Tichy, Lu Lu, George F. Babcock, James M. Wells, Rachid Drissi, John J. Bissler, Peter J. Stambrook, Paul R. Andreassen, Lisa Wiesmüller & Susanne I. Wells. (2011) The human DEK oncogene regulates DNA damage response signaling and repair. Nucleic Acids Research 39:17, pages 7465-7476.
Crossref
Crossref
Jing ZHU, Xiao-Pei SHEN, Hui XIAO, Yang ZHANG, Jing WANG & Zheng GUO. (2010) Identifying candidate cancer genes based on co-evolving gene modules. Hereditas (Beijing) 32:7, pages 694-700.
Crossref
Crossref
Erica Riveiro-Falkenbach & María S. Soengas. (2010) Control of Tumorigenesis and Chemoresistance by the DEK Oncogene. Clinical Cancer Research 16:11, pages 2932-2938.
Crossref
Crossref
Songying Han, Yanhua Xuan, Shuangping Liu, Meihua Zhang, Dongzhu Jin, Renshun Jin & Zhenhua Lin. (2009) Clinicopathological significance of DEK overexpression in serous ovarian tumors. Pathology International 59:7, pages 443-447.
Crossref
Crossref
Maria J Soares, Mafalda Pinto, Rui Henrique, Joana Vieira, Nuno Cerveira, Ana Peixoto, Ana T Martins, Jorge Oliveira, Carmen Jerónimo & Manuel R Teixeira. (2009) CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas. Modern Pathology 22:6, pages 744-752.
Crossref
Crossref
Dong-Wook Kim, Jung-IL Chae, Ji-Young Kim, Jhang Ho Pak, Deog-Bon Koo, Young Yil Bahk & Sang-Beom Seo. (2009) Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK. Journal of Cellular Biochemistry 106:6, pages 1048-1059.
Crossref
Crossref
Trisha M. Wise-Draper, Rachael A. Mintz-Cole, Teresa A. Morris, David S. Simpson, Kathryn A. Wikenheiser-Brokamp, Mark A. Currier, Timothy P. Cripe, Gerard C. Grosveld & Susanne I. Wells. (2009)
Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation
In vitro
and
In vivo
. Cancer Research 69:5, pages 1792-1799.
Crossref
Crossref
Trisha M. Wise-Draper, Richard J. Morreale, Teresa A. Morris, Rachael A. Mintz-Cole, Elizabeth E. Hoskins, Scott J. Balsitis, Nader Husseinzadeh, David P. Witte, Kathryn A. Wikenheiser-Brokamp, Paul F. Lambert & Susanne I. Wells. (2009) DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation Program. The American Journal of Pathology 174:1, pages 71-81.
Crossref
Crossref
Florian Nolte & Wolf-K. Hofmann. (2008) Myelodysplastic syndromes: molecular pathogenesis and genomic changes. Annals of Hematology 87:10, pages 777-795.
Crossref
Crossref
Lykke Grubach, Caroline Juhl-Christensen, Anita Rethmeier, Lene Hyldahl Olesen, Anni Aggerholm, Peter Hokland & Mette Østergaard. (2008) Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. European Journal of Haematology 81:2, pages 112-122.
Crossref
Crossref
Malin Ageberg, Kristina Drott, Tor Olofsson, Urban Gullberg & Anders Lindmark. (2008) Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis. Genes, Chromosomes and Cancer 47:4, pages 276-287.
Crossref
Crossref
Simin HuJ. Sunil Rao. (2017) Statistical Redundancy Testing for Improved Gene Selection in Cancer Classification Using Microarray Data. Cancer Informatics 3, pages 117693510700300.
Crossref
Crossref
Daniela Hoeller, Christina-Maria Hecker & Ivan Dikic. (2006) Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nature Reviews Cancer 6:10, pages 776-788.
Crossref
Crossref
Morgan Sammons, Shan Shan Wan, Nancy L. Vogel, Edwin J. Mientjes, Gerard Grosveld & Brian P. Ashburner. (2006) Negative Regulation of the RelA/p65 Transactivation Function by the Product of the DEK Proto-oncogene. Journal of Biological Chemistry 281:37, pages 26802-26812.
Crossref
Crossref
M. Golemović, M. Sučić, R. Zadro, S. Mrsić, M. Mikulić, B. Labar, L.j. Rajić & D. Batinić. (2006) IgH and TCRγ gene rearrangements, cyclin A1 and HOXA9 gene expression in biphenotypic acute leukemias. Leukemia Research 30:2, pages 211-221.
Crossref
Crossref
Corinna Grasemann, Sandrine Gratias, Harald Stephan, Andreas Schüler, Alexander Schramm, Ludger Klein-Hitpass, Harald Rieder, Stephanie Schneider, Ferdinand Kappes, Angelika Eggert & Dietmar R Lohmann. (2005) Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene 24:42, pages 6441-6449.
Crossref
Crossref
Joanne Cleary, Kajal V. Sitwala, Michael S. Khodadoust, Roland P.S. Kwok, Nirit Mor-Vaknin, Marek Cebrat, Philip A. Cole & David M. Markovitz. (2005) p300/CBP-associated Factor Drives DEK into Interchromatin Granule Clusters. Journal of Biological Chemistry 280:36, pages 31760-31767.
Crossref
Crossref
L Garçon, M Libura, E Delabesse, F Valensi, V Asnafi, C Berger, C Schmitt, T Leblanc, A Buzyn & E Macintyre. (2005) DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification. Leukemia 19:8, pages 1338-1344.
Crossref
Crossref
George Alexander Follows, Hiromi Tagoh, Stephen John Richards, Svitlana Melnik, Helen Dickinson, Erica de Wynter, Pascal Lefevre, Gareth John Morgan & Constanze Bonifer. (2005) c-FMS chromatin structure and expression in normal and leukaemic myelopoiesis. Oncogene 24:22, pages 3643-3651.
Crossref
Crossref
Jon C. Strefford, Irina Stasevich, Tim M. Lane, Yong-Jie Lu, Tim Oliver & Bryan D. Young. (2005) A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma. Cancer Genetics and Cytogenetics 159:1, pages 1-9.
Crossref
Crossref